|
National Stock Number(NSN): 6505-01-316-2805 (6505013162805, 013162805)
| NIIN: |
01-316-2805 |
Item Name: |
PROPOFOL INJECTION |
INC: |
45977
|
| FSC: |
6505
|
Assignment Date: |
Mar-08-1990 |
CRIT: |
N |
IIG: |
45977 |
| ISC: |
2 |
Date Standardized: |
Mar-08-1990 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-01-2002 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
90-0032 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
DIPRIVAN |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
DIPRIVAN INJECTION |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00038-0290-20 |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
5 |
9 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00310-0290-20 |
13992
|
ZENECA INC ZENECA PHARMACEUTICALS GROUP STUART PHARMACEUTICALS |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$34.49 |
PG |
|
C2201X- |
Aug-01-1997 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$34.49 |
PG |
|
------- |
Jan-01-1996 |
H |
| DM |
JDC |
L |
Z |
M |
U |
1 |
M |
$34.49 |
PG |
|
13M4--1 |
Jan-01-1996 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$34.49 |
PG |
|
9L----A |
Oct-01-1997 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$34.49 |
PG |
|
------- |
Jan-01-1996 |
H |
| VA |
JVS |
I |
|
M |
U |
1 |
V |
$0.00 |
PG |
|
------- |
Oct-01-1993 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 5EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
10.000 MILLIGRAMS PROPOFOL EQUIVALENT PER MILLILITER |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
AMPUL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
20.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
5 |
| CSGS |
ADMINISTRATION |
INTRAVENOUS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
DIPRIVAN INJECTION |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUPP |
SUPPLEMENTARY FEATURES |
D-DAY ITEM FOR DOD |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-22-1996 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-22-1996 |
3 |
H |
|
|
|
|
| MC15 |
|
Jul-22-1996 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-22-1996 |
3 |
H |
|
|
|
|
| V542 |
|
Oct-12-1993 |
0 |
0 |
|
|
54 |
54 |
|